Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Pain-Signaling Protein Activates T Cells Too

TRPV1, normally thought of as a sensory receptor, also regulates immune cells

by Lauren K. Wolf
October 13, 2014 | A version of this story appeared in Volume 92, Issue 41

When T cells recognize a dangerous pathogen, they kick into gear and attack. One crucial step in the activation of these immune cells involves a protein receptor called CRAC opening and allowing calcium ions to rush inside the cells. Or so scientists thought. A research team led by Wilfred A. Jefferies of the University of British Columbia and Eyal Raz of the University of California, San Diego, has demonstrated that another receptor, TRPV1, also helps spur T cells into action (Nat. Immunol. 2014, DOI: 10.1038/ni.3009). Not normally associated with the immune system, TRPV1 is well-known for its role in pain sensing: The receptor becomes active and sends distress signals to the brain in response to heat and the chili pepper compound capsaicin. Using electrophysiology, genetic engineering, and other tools, Jefferies, Raz, and coworkers have shown that TRPV1 regulates T cell calcium ion influx. When the experimental cinnamide compound SB366791 blocked TRPV1 in mice afflicted by colitis, the inflammation in their gut walls declined. Because SB366791 worked at a low dose, Raz says the team’s discovery might mean a second chance for TRPV1 blockers: as autoimmune disease therapies. Tested in humans as painkillers, some of these compounds have caused side effects such as fevers at high doses.

[+]Enlarge
Credit: Nat. Immunol.
A mouse with colitis has an inflamed gut lining (left). When genetically engineered to lack the receptor TRPV1, a colitis-afflicted mouse has a healthier gut (right).
Image on the left is the enflamed gut lining of a mouse with colitis. Image on the right is the less enflamed gut lining of a colitis-ridden mouse engineered to lack the receptor TRPV1.
Credit: Nat. Immunol.
A mouse with colitis has an inflamed gut lining (left). When genetically engineered to lack the receptor TRPV1, a colitis-afflicted mouse has a healthier gut (right).

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.